CAMP4 Therapeutics Corp. (CAMP)
4.01
+0.01
(+0.25%)
USD |
NASDAQ |
Oct 05, 16:00
4.03
+0.02
(+0.50%)
After-Hours: 20:00
CAMP4 Therapeutics Price : 4.01 for Oct. 5, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 05, 2026 | 4.00 | 4.09 | 3.74 | 4.01 | 381158.0 |
| Oct 02, 2026 | 3.90 | 4.05 | 3.69 | 4.00 | 367956.0 |
| Oct 01, 2026 | 3.99 | 4.152 | 3.76 | 3.84 | 994722.0 |
| Sep 30, 2026 | 3.96 | 4.09 | 3.86 | 4.04 | 170662.0 |
| Sep 29, 2026 | 3.87 | 4.02 | 3.81 | 3.91 | 172539.0 |
| Sep 28, 2026 | 3.86 | 3.95 | 3.73 | 3.85 | 116913.0 |
| Sep 25, 2026 | 3.83 | 4.06 | 3.724 | 3.92 | 477403.0 |
| Sep 24, 2026 | 3.78 | 3.94 | 3.675 | 3.84 | 130349.0 |
| Sep 23, 2026 | 4.13 | 4.27 | 3.65 | 3.72 | 192932.0 |
| Sep 22, 2026 | 4.21 | 4.24 | 3.86 | 4.15 | 161168.0 |
| Sep 21, 2026 | 4.27 | 4.32 | 4.10 | 4.17 | 289479.0 |
| Sep 18, 2026 | 4.03 | 4.27 | 3.945 | 4.24 | 1.043M |
| Sep 17, 2026 | 3.96 | 4.25 | 3.93 | 4.03 | 93441.00 |
| Sep 16, 2026 | 4.19 | 4.37 | 3.84 | 3.86 | 300787.0 |
| Sep 15, 2026 | 4.23 | 4.275 | 4.03 | 4.19 | 175272.0 |
| Sep 14, 2026 | 4.26 | 4.49 | 4.18 | 4.25 | 167038.0 |
| Sep 11, 2026 | 4.46 | 4.54 | 4.21 | 4.25 | 101147.0 |
| Sep 10, 2026 | 4.30 | 4.495 | 4.145 | 4.34 | 115644.0 |
| Sep 09, 2026 | 4.45 | 4.50 | 4.33 | 4.33 | 79917.00 |
| Sep 08, 2026 | 4.40 | 4.53 | 4.30 | 4.40 | 280483.0 |
| Sep 04, 2026 | 4.45 | 4.64 | 4.331 | 4.41 | 131118.0 |
| Sep 03, 2026 | 3.87 | 4.53 | 3.76 | 4.49 | 1.281M |
| Sep 02, 2026 | 3.85 | 4.070 | 3.78 | 3.80 | 215204.0 |
| Sep 01, 2026 | 3.85 | 3.95 | 3.70 | 3.79 | 229392.0 |
| Aug 31, 2026 | 4.18 | 4.18 | 3.87 | 3.96 | 190292.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| MannKind Corp. | 3.82 |
| Ocugen, Inc. | 1.04 |
| ACADIA Pharmaceuticals, Inc. | 20.11 |
| Alnylam Pharmaceuticals, Inc. | 219.89 |
| Savara, Inc. | 4.78 |
Price Related Metrics
| PS Ratio | 46.38 |
| Earnings Yield | -55.49% |
| Market Cap | 208.23M |